United Therapeutics | UTHR - Ordinary Share Capital


United Therapeutics reported $42.9M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Amarin USD 20.8M 28K Sep/2025
Ardelyx USD 238.02M 1.13M Dec/2024
Baxter International USD 683M 0 Dec/2024
Bayer EUR 982.42M 0 Sep/2025
Biogen USD 146.7M 200K Sep/2025
BioMarin Pharmaceutical USD 192.1M 97K Sep/2025
Gilead Sciences USD 1.24B 0 Sep/2025
GlaxoSmithKline GBP 4.03B 119.13M Sep/2025
Halozyme Therapeutics USD 117.52M 98K Sep/2025
Insmed USD 212.58M 210.76M Sep/2025
Ionis Pharmaceuticals USD 161.14M 160.98M Sep/2025
J&J USD 2.41B 584K Sep/2025
Moderna USD 391M 2M Sep/2025
Pfizer USD 5.69B 1000K Sep/2025
PTC Therapeutics USD 79.93M 554K Sep/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Sarepta Therapeutics USD 104.77M 7.06M Sep/2025
Teva Pharmaceutical Industries USD 1.15B 0 Dec/2025
United Therapeutics USD 42.9M 42.1M Sep/2025
Vertex Pharmaceuticals USD 254M 2.29M Sep/2025